What's The BUZZ?

Market News, Products, Services, and Trends

Advertisement
QI Medical

Modernizing Drug Development with Virtual Control Groups

Together with Sanofi, we’re developing VCGs to reduce the need for animals in research


Unlock the Potential of Virtual Control Groups
Charles River and Sanofi will collaborate to pilot VCGs in nonclinical toxicology programs with the goal of reducing animal usage by replacing selected control group animals with selected matched virtual control animals developed using retrospective datasets. 


In a typical animal study, approximately 25% of the animals are used as controls. VCGs have the capability to reduce the number of animals needed for these studies by reusing the measurement data gathered from these control groups. The joint vision of this initiative is to combine the science of toxicology with the power of machine learning to drive greater use of VCGs for nonclinical research across the industry. Read more >

Charles River

Charles River News & Announcements

In today’s world, quality and compliance are non-negotiable, and yesterday’s standards are no longer sufficient to meet the demands of a constantly evolving landscape. The field of quality control microbiology is undergoing a disruptive revolution to safeguard patient safety, evolving beyond traditional methods to optimize resources, minimize human error, enable sustainable alternatives, and maintain consistent quality standards. Every test, every result, and every data point define the success of life-changing therapies. That’s why we’re leading a new paradigm, one that redefines efficiency, sustainability, and innovation. Let’s rethink the future of microbial quality control, where modern, automated, data-centric, and scalable solutions are the norm, empowering you to stay ahead in a dynamic regulatory and operational landscape.  Together, we are not just preparing for the future. We’re rethinking it. Because every moment matters.

10-rxinsider-staff

Posted by: RXinsider Staff

RXinsider is a multimedia publishing and technology company offering print publications, digital platforms, events, and content creation services to the B2B pharmacy market.

SUBSCRIBE

Name
Subscription Choices
Checkboxes

Request information from Modernizing Drug Development with Virtual Control Groups

Name
Address
Subscribe